In the context of HNCs, DNA-PK overexpression appears to be significantly associated with decreased survival in NPC patients, suggesting that it may be used as a prognostic biomarker for this particular HNC subtype [156]. The gene discussed is PRKDC; the disease is nasopharyngeal carcinoma.